Lisata Therapeutics Inc. (LSTA) — Cash Flow Reinvestment Rate

Latest as of June 2020: 0.00x

Lisata Therapeutics Inc. (LSTA) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $12.00K (capex $12.00K ) from operating cash flow of $4.50 Million. Explore LSTA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$12.00K
Capex + Investments

Operating Cash Flow

$4.50 Million
USD

Capital Expenditures

$12.00K
USD

Lisata Therapeutics Inc. Cash Flow Reinvestment Rate (1992–2002)

Historical reinvestment intensity for Lisata Therapeutics Inc. across 3 annual periods. Also explore LSTA total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Lisata Therapeutics Inc. (1992–2002)

Year-by-year capital reinvestment analysis for Lisata Therapeutics Inc.. For live market cap and broader valuation context, see Lisata Therapeutics Inc. market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2002 0.00x $1.13K $1.01 Million $1.13K ▼ -99.9%
1993 1.06x $500.00K $470.00K $500.00K ▲ +219.1%
1992 0.33x $80.00K $240.00K $80.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow